Title: Methods for the determination in serum and urine
1 Methods for the determination in serum and urine
2Types of enzymes
- - The International Union of Biochemistry (IUB)
in 1964 has suggested that enzymes are arranged
in groups according to their functional catalytic
activities.
3Examples Type Group No.
i) lactate dehydogenase ii) glucose oxidase iii) tyrosinase Oxidoreductase i) anaerobic dehydrogenase ii) aerobic oxidase iii) aerobic dehydrogenase 1
Alanine amino transfesrase (ALT) Aspartate amino transferase (AST) Creatine Kinase (CK) Transferases 2
Lipase Cholinesterase Hydolases 3
Pyruvate decarboxylase Lyases 4
Triphosphate isomerase Isomerase 5
Acetyl CoA synthetase Ligases 6
4Types of enzymes
- Enzyme Commision (EC) International enzyme
numbering system - 4 figures separated by dotes e.g. 1.1.2.1
- Explanation
- 1. 1. 2.
1. - Group no group acted on subgroup acted on
the individual enzyme
5General consideration in enzyme assays in the
clinical laboratory
- In enzyme assays the activity of the enzyme and
not the enzyme concentration is measured - Clinically important enzymes, i.e. Enzymes of
diagnostic value, are those whose activities are
reflective of the condition of a certain function
in the body or an organ and the determination of
their activity will assist in the diagnosis or
the management of diseases in the patient.
6General consideration in enzyme assays in the
clinical laboratory
- Serum is the preferred specimen type for enzyme
assays - Avoid haemolysis
- RBCs contain high concentration of some enzymes
such as LDH, transferases and G6PD - Haemoglobin may interfere with some assays
especially those which include color production
7General consideration in enzyme assays in the
clinical laboratory
- Never shake the serum or the reaction mixture
vigorously as this may denature the enzyme, mix
the serum and reagent gently. - Avoid using NaF/ K oxalate tube as NaF is a
enzyme inhibitor - Check if the patient is taking drugs that effect
enzyme activity
8General consideration in enzyme assays in the
clinical laboratory
- Avoid prolonged application of tourniquet as it
effect some enzymes such as LDH - Note the physical condition of the patient (e.g.
exercise or long walk may effect CK activity) - Some enzymes are sex related i.e. higher or
present in one sex type (e.g. prostatic ACP) - Some enzymes are age related (e.g. ALP)
9General consideration in enzyme assays in the
clinical laboratory
- Some enzymes catalyze both direction of the
reaction while others catalyze one direction only - Many enzymes exit as isoenzymes (different forms
in different organs), such enzymes have a good
diagnostic value, the isoenzyme related to the
organ should be analyzed together with the total
enzyme activity e.g. CK CK-MB
10General consideration in enzyme assays in the
clinical laboratory
- Because the enzyme activity is measured, many
conditions affect such reactions and include - Substrate type and concentration
- Product type and concentration
- Amount of enzyme present
- Buffer type and pH
- Activators and Coenzymes
- Temperature of the reaction
- Specificity of the enzyme to substrate
- Presence of inhibitors
- Direction of reaction (forward or reverse
direction)
11General consideration in enzyme assays in the
clinical laboratory
- Due to the effects of various conditions on
enzyme activity, each lab must determine its
normal range for the enzymes in question and not
rely on published data. - The effect of the various conditions on enzyme
activity make enzyme assays less precise than
other smaller analytes so a coefficient of
variation (cv) of up to 10 is acceptable.
12General consideration in enzyme assays in the
clinical laboratory
- Kinetic enzyme (rate of reaction ) assays are to
be used instead of end point (two-point) assays
because they provided better accuracy.
13Some enzymes of diagnostic importance.
- 1) Creatine kinase (creatine phosphokinase) (CK)
(EC 2.7.3.2) - Activity CK
- Catalyzes the reaction ATP creatine
ADP creatine phosphate - CK isoenzymes and clinical importance
- Isoenzyme tissue or organ present
- CK-BB (CK-1) brain 98
- CK-MB (CK-2) heart muscle 20
- CK-MM (CK-3) muscle 96
141) Creatine kinase (creatine phosphokinase) (CK)
(EC 2.7.3.2)
- Method of analysis
- Continuous monitoring (kinetic) method
- (Scandinavian Committee on Enzyme, 1979)
- (Association of Clinical Biochemists, UK, 1980)
- Specimen
- Fasting serum (preferred)
- 50µmol/L N-acetylcysteine is added to serum
immediately after separation (activator for CK) - Storage at 40C for up to 2 days
- Storage at 200C for up to 30 days
- Avoid haemolysis
- Never repeat thaw-freeze
151) Creatine kinase (creatine phosphokinase) (CK)
(EC 2.7.3.2)
- Principle
- This is a rate kinetic method based on the
reverse reaction of the enzyme and coupled to
other enzyme reactions. - CK
- Creatine phosphate ADP
ATP creatine - hexokinase
- ATP glucose ADP
Glucose-6-phosphate -
- G-6-P Dehydrogenase
- 3. G-6-P NADP
6-phosphogluconate NADPH H
161) Creatine kinase (creatine phosphokinase) (CK)
(EC 2.7.3.2)
- Principle
- The rate of formation of ATP is monitored using
- the increase in absorbance at 340 nm of NADPH
- formed by the coupled reactions.
17Some enzymes of diagnostic importance.
- 2) Lactate dehydrogenase (LD) (EC 1.1.1.27)
- This is a universal enzyme occurring in almost
all tissues of the body with higher concentration
in cardiac muscle, skeletal muscle, liver, kidney
rbc - Activity Catalyzes the reaction
- LD
- Lactate NAD Pyruvate
NADH H
182) Lactate dehydrogenase (LD) (EC 1.1.1.27)
- Iso-enzymes of LD and clinical importance
Clinical significant Site in circulation Subunit LD iso-enzyme
MI Haemolytic anaemia Haemolyzed sample Acute renal failure Heart RBC Renal cortex 14-26 29-39 HHHH HHHM LD1 LD2
Pulmonary pneumonia Lymphocytosis Acute pancreatitis Lung Lymphocyte Pancrease 20-26 HHMM LD3
Hepatic carcinoma Hepatic necrosis Skeletal muscle injury Liver Skeletal muscle 8-16 8-16 HMMM MMMM LD4 LD5
192) Lactate dehydrogenase (LD) (EC 1.1.1.27)
- In normal adult circulation LD2 gt LD1, MI LD1 gt
LD2 and the LD1 gt LD2 ratio is gt1. This called
flipped LD pattern. - Method of analysis
- Continuous monitoring (kinetic) method
- (Scandinavian Committee on Enzymes, 1974)
- Specimen
- Fasting serum (preferred)
- Avoid haemolysis
- Never repeat thaw-freeze
202) Lactate dehydrogenase (LD) (EC 1.1.1.27)
- Principle
- This is a kinetic method based on the reverse
reaction of the enzyme - LD
- Pyruvae NADH H
Lactate NAD - The rate of reaction is monitored as pyruvate is
converted to lactate by observing the decrease in
absorbance at 340 nm as NADH is oxidized to NAD -
- This is faster than the forward reaction
- Less expensive than the forward reaction
- It requires less concentration of reagents